相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized controlled trial of deutetrabenazine for tardive dyskinesia The ARM-TD study
Hubert H. Fernandez et al.
NEUROLOGY (2017)
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Karen E. Anderson et al.
LANCET PSYCHIATRY (2017)
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A. Hauser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis
Angela O'Brien
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs
A. -S. Seigneurie et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2016)
Propranolol therapy for Tardive dyskinesia: A retrospective examination
Jaime M. Hatcher-Martin et al.
PARKINSONISM & RELATED DISORDERS (2016)
Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients
Yasushi Ikarashi et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials
W. Zheng et al.
PHARMACOPSYCHIATRY (2016)
Drug-Induced Extrapyramidal Syndromes Implications for Contemporary Practice
Stanley N. Caroff et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Christopher F. O'Brien et al.
MOVEMENT DISORDERS (2015)
Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder
Leslie J. Cloud et al.
NEUROTHERAPEUTICS (2014)
Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia
Julie Eve Desmarais et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions
Hideki Okamoto et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Switching From Clozapine to Zotepine in Patients With Schizophrenia A 12-Week Prospective, Randomized, Rater Blind, and Parallel Study
Chao-Cheng Lin et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
Roongroj Bhidayasiri et al.
NEUROLOGY (2013)
Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study
Itzhak Kimiagar et al.
JOURNAL OF NEUROLOGY (2012)
Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial
Yusuke Iwata et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
Joseph Jankovic et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
Stanley N. Caroff et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Long-Stay Psychiatric Patients: A Prospective Study Revealing Persistent Antipsychotic-Induced Movement Disorder
P. Roberto Bakker et al.
PLOS ONE (2011)
Spectrum of tardive syndromes: clinical recognition and management
Roongroj Bhidayasiri et al.
POSTGRADUATE MEDICAL JOURNAL (2011)
Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry
Miquel Bernardo et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2011)
THE INFLUENCE OF ANTICHOLINERGIC TREATMENT ON TARDIVE DYSKINESIA CAUSED BY NEUROLEPTIC DRUGS:
M. Reunanen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Tetrabenazine, A Monoamine-Depleting Drug Used in the Treatment of Hyperkinetic Movement Disorders
David R. P. Guay
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2010)
Effects of Amantadine on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study
Sofia Pappa et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study
Cecilia Adrianzen et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications: A Prospective Cohort Study
Scott W. Woods et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Use of aripiprazole in tardive dyskinesia: An open label study of six cases
Rajaprabhakaran Rajarethinam et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study
Haya Ascher-Svanum et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Effects of levetiracetam on tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Scott W. Woods et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia
Leonardo Cortese et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: An open-label study
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Treatment of clozapine-associated tardive dyskinesia
Chao-Cheng Lin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Botulinum toxin in the treatment of orofacial tardive dyskinesia: A single blind study
Christina W. Slotema et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Vitamin B6 treatment for tardive dyskinesia:: A randomized, double-blind, placebo-contyolled, crossover study
Vladimir Lerner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: A 16-week open trial
Jung Goo Lee et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: A randomized, double-blind, placebo-controlled crossover study
Igor Libov et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Tardive dyskinesia
Karla Soares-Weiser et al.
SEMINARS IN NEUROLOGY (2007)
Treatment of tardive dyskinesia with galantamine: A randomized controlled crossover trial
Stanley N. Caroff et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
S Janno et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
分享论文
